PIK3CD and neoplasm: BAY 80-6946 displayed a strong activity of the PI3K signaling pathway inhibiting AKT (Thr308 and Ser473) as well as PRAS40, 4EBP1, and FOXOs phosphorylation in tumor cells carrying PIK3CA activating mutations.